Skip to main content
Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.979
-0.022 (-2.15%)
At close: Dec 20, 2024, 4:00 PM
0.980
+0.001 (0.15%)
After-hours: Dec 20, 2024, 5:41 PM EST

Biofrontera Revenue

Biofrontera had revenue of $9.01M in the quarter ending September 30, 2024, with 1.30% growth. This brings the company's revenue in the last twelve months to $35.36M, up 5.17% year-over-year. In the year 2023, Biofrontera had annual revenue of $34.07M with 18.82% growth.

Revenue (ttm)
$35.36M
Revenue Growth
+5.17%
P/S Ratio
0.12
Revenue / Employee
$415,976
Employees
85
Market Cap
7.58M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.07M5.40M18.82%
Dec 31, 202228.67M4.57M18.98%
Dec 31, 202124.10M5.25M27.86%
Dec 31, 202018.85M-7.33M-28.01%
Dec 31, 201926.18M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Meihua International Medical Technologies 94.25M
XWELL 33.83M
Precipio 17.41M
NeuroMetrix 3.77M
Soligenix 364.18K
Virax Biolabs Group 84.87K
Revenue Rankings

BFRI News

More News